203 related articles for article (PubMed ID: 23462923)
21. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
[TBL] [Abstract][Full Text] [Related]
22. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
Bouizar Z; Spyratos F; De vernejoul MC
J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
[TBL] [Abstract][Full Text] [Related]
23. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.
Burton DW; Geller J; Yang M; Jiang P; Barken I; Hastings RH; Hoffman RM; Deftos LJ
Prostate; 2005 Feb; 62(3):275-81. PubMed ID: 15389781
[TBL] [Abstract][Full Text] [Related]
25. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.
Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A
Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637
[TBL] [Abstract][Full Text] [Related]
26. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
28. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
[TBL] [Abstract][Full Text] [Related]
29. Cancer Diagnostics via Ultrasensitive Multiplexed Detection of Parathyroid Hormone-Related Peptides with a Microfluidic Immunoarray.
Otieno BA; Krause CE; Jones AL; Kremer RB; Rusling JF
Anal Chem; 2016 Sep; 88(18):9269-75. PubMed ID: 27558535
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
31. Significance of the parathyroid hormone-related protein expression in breast carcinoma.
Yoshida A; Nakamura Y; Shimizu A; Harada M; Kameda Y; Nagano A; Inaba M; Asaga T
Breast Cancer; 2000; 7(3):215-20. PubMed ID: 11029801
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
33. The Diagnostic Value of Serum miR-129 in Breast Cancer Patients with Bone Metastasis.
Wang C; Pang L; Shi Q; Liu X; Liu Y
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013342
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.
Linforth R; Anderson N; Hoey R; Nolan T; Downey S; Brady G; Ashcroft L; Bundred N
Clin Cancer Res; 2002 Oct; 8(10):3172-7. PubMed ID: 12374685
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811
[TBL] [Abstract][Full Text] [Related]
36. Cross-linked collagen C- and N-telopeptides for an early diagnosis of bone metastasis from breast cancer.
Kiuchi K; Ishikawa T; Hamaguchi Y; Momiyama N; Hasegawa S; Ishiyama A; Kono T; Doi T; Chishima T; Shimada H
Oncol Rep; 2002; 9(3):595-8. PubMed ID: 11956634
[TBL] [Abstract][Full Text] [Related]
37. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
38. Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.
Shaker OG; Helmy HS
Clin Breast Cancer; 2018 Jun; 18(3):e321-e328. PubMed ID: 28645722
[TBL] [Abstract][Full Text] [Related]
39. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer metastasis to bone: it is not all about PTHrP.
Bendre M; Gaddy D; Nicholas RW; Suva LJ
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]